MA (EU) number 
EU/1/01/176/001 
(Invented) 
name 
Zometa 
Strength 
4 mg 
EU/1/01/176/002 
Zometa 
4 mg 
EU/1/01/176/003 
Zometa 
4 mg 
EU/1/01/176/004 
Zometa 
4 mg/5 ml 
EU/1/01/176/005 
Zometa 
4 mg/5 ml 
EU/1/01/176/006 
Zometa 
4 mg/5 ml 
Pharmaceutical 
form 
Powder and solvent 
for solution for 
infusion 
Powder and solvent 
for solution for 
infusion 
Powder and solvent 
for solution for 
infusion 
Concentrate for 
solution for infusion 
Concentrate for 
solution for infusion 
Concentrate for 
solution for infusion 
Route of 
administration 
Intravenous use 
Intravenous use 
Intravenous use 
Immediate 
packaging 
powder: vial 
(glass); solvent: 
ampoule (glass) 
powder: vial 
(glass); solvent: 
ampoule (glass) 
powder: vial 
(glass); solvent: 
ampoule (glass) 
Content 
(concentration) 
powder: 4 mg; 
solvent: 5 ml 
Pack size 
1 vial + 
1 ampoule 
powder: 4 mg; 
solvent: 5 ml 
4 vials + 
4 ampoules 
powder: 4 mg; 
solvent: 5 ml 
Intravenous use 
vial (plastic) 
5 ml 
Intravenous use 
vial (plastic) 
5 ml 
4 vials 
Intravenous use 
vial (plastic) 
5 ml 
EU/1/01/176/007 
EU/1/01/176/008 
Zometa 
Zometa 
4 mg/100 ml  Solution for infusion 
4 mg/100 ml  Solution for infusion 
Intravenous use 
Intravenous use 
bottle (plastic) 
bottle (plastic) 
100 ml 
100 ml 
EU/1/01/176/009 
Zometa 
4 mg/100 ml  Solution for infusion 
Intravenous use 
bottle (plastic) 
100 ml 
1/1 
10 (10x 
1+1) vials + 
ampoules 
(multi-pack) 
1 vial 
10 (10x1) 
vials 
(multi-pack) 
1 bottle 
4 (4x1) 
bottles 
(multi-pack) 
5 (5x1) 
bottles 
(multi-pack) 
 
